Abstract: Early detection is crucial for timely intervention aimed at pre-venting and slowing the progression of neurocognitive disorder (NCD), a common and significant health problem among the aging ...

Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.

Neurodevelopmental disorders (NDD), as defined by DSM-5-TR and CDDR, comprise heterogeneous early-onset conditions involving executive dysfunction, motor planning deficits, language impairments, and ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

Developmental language disorder (DLD) affects around two children in each class. It hinders their acquisition and use of language, even if they do not have other auditory, intellectual or neurological ...